Skip to main content

Call for papers - Vaccine hesitancy

Guest Editors

Subhash Chandir, PhD, MBBS, MPH, CPH, IRD Global, USA
Heidi J. Larson, PhD, London School of Hygiene & Tropical Medicine, UK

Submission Status: Open   |   Submission Deadline: 27 December 2024

BMC Public Health is calling for submissions to our Collection on Vaccine hesitancy. This initiative aims to deepen our understanding of the global challenge posed by vaccine hesitancy, which threatens the historic successes of immunization programs.
Vaccines have been instrumental in preventing millions of deaths and controlling diseases like smallpox and polio. However, the rise in vaccine hesitancy jeopardizes public health by compromising herd immunity.
We welcome submissions exploring themes such as determinants, communication strategies, and interventions to counter vaccine hesitancy. Join us in addressing this critical issue to sustain the positive impact of vaccines on a global scale.

New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health and Well-being and SDG 10: Reduced Inequality.

Meet the Guest Editors

Back to top

Subhash Chandir, PhD, MBBS, MPH, CPH, IRD Global, USA

Dr Subhash Chandir is Senior Epidemiologist and Director at IRD Global. He earned his medical degree from Pakistan and pursued a Masters in Public Health (Infectious Diseases) and doctorate in Global Disease Epidemiology and Control from Johns Hopkins University. Over the past two decades, Dr Chandir has conducted or participated in various studies and projects in Pakistan, Bangladesh, Indonesia, Kenya, Nigeria, Peru, Ecuador, UAE, and the USA. His research and teaching efforts have been focused on several critical areas, including infectious disease epidemiology, surveillance, immunizations, women and child health, economic incentives, training of frontline health workers, digital health, electronic registries, geospatial monitoring, big data analytics, and operational research. Dr Chandir serves on the faculty at Johns Hopkins Bloomberg School of Public Health, and is a member of the WHO Digital Health Technical Advisory Group.

Heidi J. Larson, PhD, London School of Hygiene & Tropical Medicine, UK; Institute of Health Metrics & Evaluation, University of Washington, USA

Heidi J. Larson, Director of the Vaccine Confidence Project, focuses her research on managing risk and building trust in the context of pandemics and other large scale crises. She recently launched the Global Listening Project to investigate ecosystems of trust. Prof Larson previously headed Global Immunization Communication at UNICEF and served on WHO’s SAGE Working Group on vaccine hesitancy. She is author of STUCK: How Vaccine Rumors Start – and Why They Don’t Go Away. In 2021, BBC named her as one of the 100 most influential women in the world. She was also awarded the 2021 Edinburgh Medal. 

About the Collection

BMC Public Health invites submissions to our new Collection, Vaccine hesitancy. This Collection seeks to deepen our understanding of the complexities surrounding vaccine hesitancy, a phenomenon with significant implications for global public health.

Vaccinations have historically played a pivotal role in curbing the spread of infectious diseases, preventing millions of deaths globally. Vaccine hesitancy undermines the effectiveness of vaccination programs, leading to decreased herd immunity and an increased risk of preventable diseases. Advances in immunization have eradicated  smallpox, significantly reduced the incidence of polio, and brought under control once-deadly diseases like measles, mumps, and rubella. 

The COVID-19 pandemic also highlighted the urgency of widespread vaccination, showcasing global collaboration and innovation. However, the success of these achievements is threatened by vaccine hesitancy, which not only puts individuals at risk but also poses a broader public health challenge by eroding the collective defenses that vaccines afford to communities. Addressing vaccine hesitancy is paramount to sustaining and advancing the positive impact of vaccines on global health.

We invite contributions related to, but not limited to, the following themes:

  • Determinants and drivers of vaccine hesitancy
  • Communication strategies to address vaccine hesitancy
  • Impact of vaccine hesitancy on vaccination coverage
  • Trust in vaccines and healthcare systems
  • Interventions and solutions to counter vaccine hesitancy

This collection supports and amplifies research related to SDG 3: “Good Health and Well-being” by promoting vaccination as a crucial preventive health measure. Additionally, addressing vaccine hesitancy supports SDG 10: “Reduced Inequality”, by ensuring equitable access to vaccines and reducing disparities in healthcare outcomes.

Image credit: Syda Productions /

  1. Human papillomavirus (HPV) infections can cause cancers of the cervix, vagina, vulva, penis, anus, and oropharynx. The most recently approved HPV vaccine, Gardasil-9, protects against HPV infection and can pre...

    Authors: Qian Lu, Lenna Dawkins-Moultin, Dalnim Cho, Naomi Q. P. Tan, Suellen Hopfer, Yisheng Li, Lois Ramondetta, Yusi Xu, Di Lun and Minxing Chen
    Citation: BMC Public Health 2024 24:1506

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Vaccine hesitancy" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.